报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 8.3% | -28.51% | 36.51% | 30/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 6.08% | 18.29% | 138.43% | 25/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 2.55% | -22.96% | -71.19% | 39/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 8.85% | -81.83% | -23.77% | 43/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 11.61% | -74.65% | 125.88% | 14/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | 5.14% | -84.53% | 55.29% | 44/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | 3.31% | -88.45% | -93.21% | 37/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | 48.72% | 218.64% | 6.38% | 6/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | 45.8% | 220.95% | 37.83% | 6/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | 33.23% | 268% | 15.95% | 7/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | 28.66% | 548.42% | 87.44% | 4/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 15.29% | -44.92% | 7.15% | 53/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 14.27% | 2% | 58.03% | 41/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 9.03% | -34.66% | 104.3% | 47/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | 4.42% | 2% | -84.08% | 35/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | 27.76% | 21.7% | 100.87% | 32/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
2020-06-30 | 13.82% | 2% | -39.41% | 32/129 | 15.16% | 圣湘生物 | 112.46% | 行业排名> |
2019-12-31 | 22.81% | 118.7% | 118.7% | 28/129 | 14.38% | 博拓生物 | 108.13% | 行业排名> |
2018-12-31 | 10.43% | 1729.83% | 1729.83% | 68/129 | 12.98% | 圣湘生物 | 29.33% | 行业排名> |
2017-12-31 | 0.57% | 2% | 2% | 92/129 | 13.82% | 健尔康 | 84.09% | 行业排名> |